Hostname: page-component-cb9f654ff-rkzlw Total loading time: 0 Render date: 2025-08-04T04:07:23.824Z Has data issue: false hasContentIssue false
  • English
  • Français

Calcium Antagonists, Cerebral Ischemia and Vasospasm

Published online by Cambridge University Press:  18 September 2015

Bryce Weir
Bryce Weir*
Affiliation:
Division of Neurosurgery, University of Alberta
*
Division of Neurosurgery, University of Alberta, Edmonton, Alberta, Canada T6G 2G3
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The past fifteen years has seen the classification of diverse substances into a group known as calcium antagonists (CAs). They have a common ability to reduce the transmembrane transport of extracellular calcium ions (CAe2+). This flow of calcium into vascular smooth muscle is ultimately associated with the development of tension and vasoconstriction. Some CAs appear to have a predilection for cerebral as opposed to systemic arteries and so may function as specific cerebral arterial vasodilators. It has been proposed that they might be useful in certain types of cerebral ischemia such as that due to arterial occlusion or prolonged vasoconstriction. Animal experiments and initial clinical trials give grounds for cautious optimism that CAs may become as useful in neurology as they have recently become in cardiology.

Information

Type
Special Features
Information
Canadian Journal of Neurological Sciences , Volume 11 , Issue 2 , May 1984 , pp. 239 - 246
Copyright
Copyright © Canadian Neurological Sciences Federation 1984

References

Allen, GS. (1977) Cerebral arterial spasm: a discussion of present and future research. Neurosurgery 1: 142–148.CrossRefGoogle ScholarPubMed
Allen, GS., Ann, HS., Preziosi, TJ., Battye, R., Boone, SC., Chou, SN., Kelly, DL., Weir, BK., Crabbe, RA., Lavik, PJ., Rosenbloom, SB., Dorsey, FC., Ingram, CR., Mellits, DE., Bertsch, LA., Boisvert, DPJ., Hundley, MB., Johnson, RK., Strom, JA., Transou, CR. (1983) Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid hemorrhage. New Engl. J. Med. 308: 619–624.CrossRefGoogle ScholarPubMed
Allen, GS., Bahr, AL. (1979) Cerebral arterial spasm: Part 10. Reversal of acute and chronic spasm in dogs with orally administered nifedipine. Neurosurgery 4: 43–47.CrossRefGoogle ScholarPubMed
Allen, GS., Banghart, SB. (1979) Cerebral arterial spasm: Part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries. Neurosurgery 4: 37–42.CrossRefGoogle ScholarPubMed
Allen, G., Gross, CJ., Henderson, LM., Chou, SN. (1976) Cerebral arterial spasm: Part 4. In vitro effects of temperature, serotonin analogues. large nonphysiological concentration of serotonin, and extracellular calcium and magnesium on serotonin-induced contractions of the canine basilar artery. J. Neurosurg. 44: 585–593.CrossRefGoogle ScholarPubMed
Angelino, PF., Tortore, P., Algranati, R. (1975) Hemodynamic studies on the new coronary therapeutic drug nifedipine (BAY a 1040). Lochner, W.Braasch, W.Kroneberg, G. (Eds.), in 2ndInternational Adalat Symposium. New Therapy of Ischemic Heart Disease. New York: Springer-Verlag, pp. 128–139.Google Scholar
Antman, EM.Stone, PH., Muller, JE., Braunwald, E. (1980) Calcium channel blocking agents in the treatment of cardiovascular disorders. Part 1. Basic and clinical electrophysiologic effects. Ann. Int. Med. 93: 875–885.CrossRefGoogle Scholar
Astrup, J.Symon, L., Branston, NM., Lassen, NA. (1977) Cortical evoked potential and extracellular K4 and H+ at critical levels of brain ischemia. Stroke 8: 51–57.CrossRefGoogle Scholar
Auer, L. (1983) Cerebrovascular activity of the calcium antagonist nimodipine. Reivich, M. and Hurtig, H.I. (Eds.), in Cerebrovascular Diseases. New York, Raven Press, pp. 437.Google Scholar
Auer, LM.Ito, Z., Suzuki, A., Ohta, H. (1982) Prevention of symptomatic vasospasm by topically applied nimodipine. Acta Neurochir. 63: 297–302.CrossRefGoogle ScholarPubMed
Auer, LM.Oberbauer, RW., Schalk, HV. (1983) Human pial vascular reactions to intravenous nimodipine-infusion during EC-IC bypass surgery. Stroke 14: 210–213.CrossRefGoogle ScholarPubMed
Baldy-Moulinier, M.Negre, Ch (1976) K+ accumulation as a pathological stimulus for dilatation or contraction of cerebral vessels. In Betz, E. (Ed.), Ionic Actionson Vascular Smooth Muscle. New York, Springer-Verlag pp. 97–100.Google Scholar
Berger, JR.Busto, R., Ginsberg, MD., Alonso, O. (1983) Calcium channel blocker: trial in global brain ischemia. Neurology 33 (Suppl. 2): 182.Google Scholar
Brandt, L.Andersson, K-E., Bengtsson, B., Edvinsson, L., Ljunggren, B., MacKenzie, ET. (1980). Effect of a calcium antagonist on cerebrovascular smooth muscle in vitro and in vivo. In Wilkins, RH. (Ed.), Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, pp. 699.Google Scholar
Brandt, L.Andersson, K-E., Edvinsson, L., Ljunggren, B. (1981) Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries. J. Cereb. Blood Flow Metab. 1: 339–347.CrossRefGoogle ScholarPubMed
Brandt, L.Ljunggren, B., Andersson, K-E., Edvinsson, L., MacKenzie, E., Tamura, A., Teasdale, G. (1983) Effects of topical application of a calcium antagonist (nifedipine) on feline cortical pial microvascula-ture under normal conditions and in focal ischemia. J. Cereb. Blood Flow Metab. 3: 44–50.CrossRefGoogle ScholarPubMed
Buhler, FR.Hulthen, UL., Bolli, P(1982) Calcium channel inhibitors for identification of mechanisms and treatment of hypertension. Cardiovasc. Pharm. 4 (Suppl. 3): S 267 – S 391.Google Scholar
Cohen, RJ.Allen, GS. (1980) Cerebral arterial spasm: the role of calcium in in vitro and in vivo analysis of treatment with nifedipine and nimodipine. In Wilkins, RH. (Ed.), Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, pp. 699.Google ScholarPubMed
Cohn, JN. (1982) Calcium-entry blockers in coronary artery disease. Circulation 65 (Part II): 11–159.Google ScholarPubMed
Editorial (1983) Calcium antagonists and aneurysmal subarachnoid hemorrhage. Lancet II: 141–143.Google Scholar
Edvinsson, L.Brandt, L., Andersson, K-E., Bengtsson, B. (1979) Effect of a calcium antagonist on experimental constriction of human brain vessels. Surg. Neurol. 11: 327–330.Google ScholarPubMed
Endo, M.Kandal, , Hosoda, S., Hayashi, H., Hirosawa, K., Konno, S. (1975) Prinzmetal’s variant form of angina pectoris: re-evaluation of mechanisms. Circulation 52: 33–37.CrossRefGoogle ScholarPubMed
Farber, JL.Chien, KR., Mittnacht, S Jr., (1981) The pathogenesis of irreversible cell injury in ischemia. Amer. J. Path. 102: 271–281.Google ScholarPubMed
Ferrari, M. (1970) Interactions between calcium and some myolytic agents on depolarized vascular smooth muscle. J. Pharm. Pharmacol. 22: 71–72.CrossRefGoogle Scholar
Flaim, SF.Zelis, R. (1982) Calcium Channel Blockers: Mechanisms of Action and Clinical Applications. Baltimore, Urban & Schwarzenberg, pp. 303.Google Scholar
Gaab, MR.Brawanski, A., Bockhorn, J., Haubitz, I., Rode, ChP., Maximilian, VA. (1982) Calcium antagonism: a new therapeutic principle in stroke and cerebral vasospasm? rCBF Bull. 3: 47–51.Google Scholar
Gelmers, HJ. (1982) Effect of nimodipine (Bay e 9736) on postischaemic cerebrovascular reactivity, as revealed by measuring regional cerebral blood flow (rCBF). Acta Neurochir. 63: 283–290.CrossRefGoogle ScholarPubMed
Haas, H.Haertfelder, G. (1962) a-lsopropyl-a-((N-methyl-N-homoveratril) -a-aminopropyl)-3, 4-dimethoxyphenylacetonitril, eine substanz mit koronargefasserweiternden eigenschaften. Arzneim. Forsch. 12: 1549–1558.Google Scholar
Harper, AM.Craigen, L., Kazda, S. (1981) Effect of the calcium antagonist, nimodipine, on cerebral blood flow and metabolism in the primate. J. Cereb. Blood Flow Metab. I: 349–356.CrossRefGoogle Scholar
Harris, RJ.Branston, NM., Symon, L., Bayhan, M., Watson, A. (1982) The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. Stroke 13: 759–766.CrossRefGoogle ScholarPubMed
Hartshorne, DJ.Mrwa, U. (1982) Regulation of smooth muscle actomyosin. Blood Vessels 19: 1–18.Google ScholarPubMed
Haws, CW.Gourley, JK., Hevstad, DD. (1983) Effects of nimodipine on cerebral blood flow. Pharmacol. Exper. Therap. 225: 24–28.Google Scholar
Hayashi, S.Toda, N. (1977) Inhibition by Cd2+, verapamil and papaverine of Ca2+-induced contractions in isolated cerebral and peripheral arteries of the dog. Brit. J. Pharmacol. 60: 35–43.CrossRefGoogle ScholarPubMed
Hoffmeister, F.Kazda, S., Krause, HP. (1979) Influence of nimodipine (Bay e 9736) on the postischaemic changes of brain function. Acta Neurol. Scand. 60 (Suppl. 72): 358–359.Google Scholar
Hogestatt, ED.Andersson, KE., Edvinsson, L. (1982) Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit. Acta Physiol. Scand. 114: 283–296.CrossRefGoogle ScholarPubMed
Hossman, KA.Paschen, W., Csiba, L. (1983) Relationship between calcium accumulation and recovery of cat brain after prolonged cerebral ischemia. J. Cereb. Blood Flow Metab. 3: 316–353.CrossRefGoogle Scholar
Kazda, S.Hoffmeister, F., Garthoff, B., Towart, R. (1979) Prevention of the postischaemic impaired reperfusion of the brain by nimodipine (Bay e 9736). Acta Neurol. Scand. 60 (Suppl. 72): 302–303.Google Scholar
Kazda, S.Towart, R. (1982) Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action. Acta Neurochir. 63: 259–265.CrossRefGoogle ScholarPubMed
Kazda, S.Garthoff, B., Krause, HP., Schlossmann, K. (1982) Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments. Arzneim. Forsch. 32: 331–338.Google ScholarPubMed
Low, RI.Takeda, P., Mason, DT., DeMaria, AN. (1982) The effects of calcium channel blocking agents on cardiovascular function. Am. J. Cardiol. 49: 547–553.CrossRefGoogle ScholarPubMed
McCalden, TA.Bevan, JA. (1981) Sources of activator calcium in the rabbit basilar artery. Am. J. Physiol. 241: H129–H133.Google ScholarPubMed
Muller-Schweinitzer, E.Neumann, P. (1983) In vitro effects of calcium antagonists PN 200–110, nifedipine, and nimodipine on human and canine cerebral arteries. J. Cereb. Blood Flow Metab. 3: 354–361.CrossRefGoogle Scholar
Nagai, H.Takagi, T., Kamiya, K., Fukuoka, H., Hotta, K. (1980) Effect of vasoactive drugs on late spasm. In Wilkins, RH. (Ed.). Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, pp. 699.Google Scholar
Nakayama, K.Kato, H. (1979) Different calcium dependency of contractile responses of cerebral artery to quick stretch and electrical stimuli. Acta Neurol. Scand. 60 (Suppl. 72): 508–509.Google Scholar
Okwuasaba, FK.Weir, BK., Cook, DA., Krueger, CA. (1981) Effects of various intracranial fluids on smooth muscle. Neurosurgery 9:402–406.CrossRefGoogle ScholarPubMed
Packer, M.Frishman, WH. (1982) Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspective. Amer. J. Cardiol. 50: 881–885.CrossRefGoogle Scholar
Pearce, WJ.Bevan, JA. (1983) The cerebrovascular selectivity of diltiazem. Programme, Annual Meeting of American Association of Neurological Surgeons, Washington: 60–61.Google Scholar
Raichle, ME. (1982) The pathophysiology of brain ischemia and infarction. Clin. Neurosurg. 29: 379–389.CrossRefGoogle ScholarPubMed
Roy, MW.Tibbs, PA., Holladay, FP., Donaldson, DL.Young, AB. (1983) Deleterious effects of verapamil following middle cerebral artery occlusion incats. Programme, Annual Meeting of American Association of Neurological Surgeons. Washington: 58–59.Google Scholar
Sandahl, B.Andersson, KE., Aronsen, KF., Ulmsten, U. (1978) Effect of the calcium antagonist nifedipine on uterine blood flow in non-treated and oestradiol-treated rats. Gynec. Obstet. Invest. 9:238–243.CrossRefGoogle ScholarPubMed
Sato, M.Nagao, T., Yamaguchi, I., Nakajima, H., Kiyomoto, A. (1971) Pharmacological studies on a new 1, 5-benzothiazepine derivative (CRD-401). I. Cardiovascular actions. Arzneim. Forsch. 21:1338–1343.Google Scholar
Schwartz, A. and Taira, N., Editors (1983) Calcium channel-blocking drugs: a novel intervention for the treatment of cardiac disease. Circ. Res. 52 (Part II): 1l–I181.Google ScholarPubMed
Shimizu, K.Ohta, T., Toda, N. (1980) Evidence for greater susceptibility of isolated dog cerebral arteries to Ca antagonists than peripheral arteries. Stroke II: 261–266.CrossRefGoogle Scholar
Skarby, T.Andersson, KE., Edvinsson, L. (1983) Influence of extracellular calcium and calcium antagonists on contractions of isolated cerebral and mesenteric arteries. Programme. Symposium - Der Zerebral Angiospasmus. Mainz. 62.Google Scholar
Sonnenblick, EH.Lesch, M. (1982 and 1983) Calcium blockers. I, II, HI. Progr. Cardiovasc. Dis. 25: 83–296.Google Scholar
Steen, PA.Newberg, LA., Milde, JH., Michenfelder, JD. (1983) Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog. J. Cereb. Blood Flow Metab. 3: 38–43.CrossRefGoogle ScholarPubMed
Svendgaard, NA.Brismar, J., Delgado, T., Egund, N., Owman, C., Rodacki, MA., Sahlin, C., Salford, LG. (1983) Late cerebral arterial spasm: The cerebrovascular response to hypercapnia, induced hypertension and the effect of nimodipine on blood flow autoregulation in experimental subarachnoid hemorrhage in primates. Gen. Pharmacol. 14: 167–172.CrossRefGoogle ScholarPubMed
Tanaka, K.Gotoh, F., Muramatsu, F., Fukuchi, Y., Amano, T., Okayasu, H., Suzuki, N. (1980) Effects of nimodipine (Bay, E 9736) on cerebral circulation in cats. Arzneim. Forsch. 30: 1494–1497.Google ScholarPubMed
Tanaka, K.Gotoh, F., Muramatsu, F., Fukuchi, Y., Okayasu, H., Suzuki, N., Kobari, M. (1982) Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats. Arzneim. Forsch. 32: 1529–1534.Google Scholar
Toda, N. (1974) Responsiveness to potassium and calcium ions of isolated cerebral arteries. Amer. J. Physiol. 227: 1206–1211.CrossRefGoogle ScholarPubMed
Towart, R. (1981) The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine. Circ. Res. 48: 650–657.CrossRefGoogle ScholarPubMed
Towart, R. (1982) The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management. Acta Neurochir. 63: 253–258.CrossRefGoogle ScholarPubMed
Towart, R.Kazda, S. (1979) The cellular mechanisms of action of nimodipine (BAYe 9736), anewcalciumantagonist. Brit. J. Pharm. 67:409–410.Google Scholar
Towart, R.Perzborn, E. (1981) Nimodipine inhibits carbocyclic throm-boxane-induced contractions of cerebral arteries. Eur. J. Pharm. 69: 213–215.CrossRefGoogle ScholarPubMed
Towart, R.Wehinger, E., Meyer, H., Kazda, S. (1982) The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. Arzneim. Forsch. 32: 338–346.Google ScholarPubMed
Van Breemen, C., Siegel, B., Kalinoski, L., Zera, P., Hwang, O. (1980) The Ca++ cycle in arterial smooth muscle. In Wilkins, RH. (Ed.), Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, pp. 699.Google Scholar
Van Nueten, JM., Vanhoutte, PM. (1981) Calcium entry blockers and vasospasm. In Vanhoutte, PM., Leusen, I. (Eds.), Vasodilatation. New York, Raven Press, pp. 459–468.Google Scholar
Varsos, VG.Liszczak, TM., Han, DH., Kistler, JP., Vielma, J., Black, PM., Héros, RC., Zervas, NT. (1983) Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a “two-hemorrhage” canine model. J. Neurosurg. 58: 11–17.CrossRefGoogle Scholar
Weir, BKA. (1980) The effect of vasospasm on morbidity and mortality after subarachnoid hemorrhage from ruptured aneurysm. In Wilkins, RH. (Ed.), Cerebral Arterial Spasm. Baltimore, Williams & Wilkins, pp. 699.Google Scholar
Weir, B.Grace, M., Hansen, J., Rothberg, C. (1978) Time course of vasospasm in man. J. Neurosurg. 48: 173–178.CrossRefGoogle ScholarPubMed
Weiss, GB. (1981) New Perspectives on Calcium Antagonists. American Physiological Society, Bethesda. Distributed by William and Wilkins Co., Baltimore, pp. 241.Google Scholar
White, RP.Cunningham, MP., Robertson, JT. (1982) Effect of the calcium nimodipine on contractile responses of isolated canine basilar arteries induced by serotonin, prostaglandin F2e>, thrombin, and whole blood. Neurosurgery 10: 344–348.CrossRefGoogle Scholar